Core Laboratories Inc. (CLB) To Go Ex-Dividend on August 10th

Core Laboratories Inc. (NYSE:CLB) declared a quarterly dividend on Wednesday, July 29th. Investors of record on Monday, August 10th will be given a dividend of 0.01 per share by the oil and gas company on Monday, August 31st. This represents a c) annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, August 10th.

Core Laboratories has decreased its dividend payment by an average of 0.3%annually over the last three years. Core Laboratories has a dividend payout ratio of 4.7% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Core Laboratories to earn $0.79 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 5.1%.

Core Laboratories Price Performance

Shares of NYSE CLB opened at $10.37 on Friday. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42. The stock has a fifty day simple moving average of $12.08 and a two-hundred day simple moving average of $15.26. Core Laboratories has a 1-year low of $9.72 and a 1-year high of $20.36. The firm has a market cap of $477.87 million, a price-to-earnings ratio of 18.51, a price-to-earnings-growth ratio of 2.38 and a beta of 1.00.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.03. Core Laboratories had a return on equity of 10.06% and a net margin of 5.10%.The firm had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. During the same period in the previous year, the company posted $0.19 earnings per share. The business’s revenue was down 4.3% on a year-over-year basis. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Analysts anticipate that Core Laboratories will post 0.53 earnings per share for the current year.

Institutional Trading of Core Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in CLB. Goldman Sachs Group Inc. lifted its holdings in Core Laboratories by 185.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock worth $13,549,000 after purchasing an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its holdings in Core Laboratories by 9.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after buying an additional 528,976 shares in the last quarter. MAC Alpha Capital Management LP purchased a new position in Core Laboratories during the 4th quarter valued at about $5,016,000. Heartland Advisors Inc. purchased a new position in Core Laboratories during the 1st quarter valued at about $2,518,000. Finally, Renaissance Technologies LLC increased its position in shares of Core Laboratories by 436.6% during the fourth quarter. Renaissance Technologies LLC now owns 183,400 shares of the oil and gas company’s stock valued at $2,940,000 after buying an additional 149,219 shares during the period. 97.81% of the stock is currently owned by institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.